Press Release: Albireo : ALBO STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE ...

(PR-inside.com) NEW YORK, NY / ACCESSWIRE / February 1, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Albireo Pharma, Inc. (NASDAQ:ALBO) to Ipsen is fair to Albireo shareholders. Per the terms of the proposed transaction, Ipsen would acquire Albireo for $42.00 per share in cash plus one contingent value right per share (CVR), entitling its holder to deferred cash payments of $10.00 per CVR payable upon the U.S. Food and Drug Administration's approval of Bylvay in the Biliary Atresia indication by December 31, 2027. Halper Sadeh encourages Albireo shareholders to click here ..